Symbiotic Healthcare develops FMT pill for C. diff infection

Symbiotic Healthcare, based in Manhattan, N.Y., has developed a capsule containing the processed fecal matter used in the C. difficile treatment fecal microbiota transplantation, according to a Crain’s New York Business report.

Advertisement

Symbiotic Healthcare was founded by North Shore-LIJ Health System infectious disease specialist Bruce Hirsch, MD, and immunologist Gerard Honig. The company’s capsule holds the processed matter and can be refrigerated for later use.

In a preliminary test including 23 patients, the pills resulted in an 87 percent cure rate.

The company is currently self-funded, but its founders are looking for financial backing, according to the report.

More Articles on Gastroenterology:
Hiring & firing: what gastroenterologists need to know about finding a stellar staff
Are C. diff infections on the move?
PPI is 3rd most-prescribed drug in the U.S.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.